Gilead Sciences
Acronym: GILD
General Information
Identification Code: 258845020786-10
Website: [object Object]
Entity Form: Corporation
Registration Category: Companies & groups
Registration Date: 2/23/2016
Last Update: 3/6/2024
EP Accredited Number: 2
Mission & Interests
Goals: Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 38 countries worldwide.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Competition
- Public health
- Research and innovation
- Trade
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: EU initiatives relevant to HIV/AIDS, Hepatitis B & C and oncology
- ATMP Regulation
- EU IP policy
- EU research policy
- EU trade policy
- Health Systems Performance Assessment
- Health Technology Assessment & Market Access
- Industrial policy
- Outcomes-based healthcare systems
- Orphan Medicinal Products Regulation
- Paediatric Regulation
- Digital Health
- Europe's Beating Cancer Plan
- Blood, tissues and cells legislation
- Sustainable Development Goals
- EC Pharma Strategy
- European Health Union
- EU4Health
- Re-opening of the general pharmaceutical legislation
Communication Activities: Support to and participation in multi-stakeholder initiatives advocating for policy initiatives towards elimination of hepatitis C, promoting improved long term health outcomes for people living with HIV and exploring policy options to improve access to cancer treatments and ATMPs across Europe;
Sponsorship of a journalistic investigation on HIV independently carried out by POLITICO Europe.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 333 LakesideFoster City
Post Code: CA94404
City: California
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: Park LaneCulliganlaan 2
Post Code: 1831
City: Diegem
Country: BELGIUM
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: This estimate includes costs attributable to covered activities, including consulting fees, meeting costs and the pro-rata salary and travel costs of Gilead Sciences' staff involved in representation to the European institutions, based on the proportion of employee time spent on these activities. The two dedicated 100% FTEs started in September 2022 and are calculated pro-rata for the financial year of 2022.
Membership Information
Members10 Percent: 2
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 4
Members F T E: 2.200000047683716
Structure
Structure Type: Structure
Is Member Of: HIV Outcomes - https://hivoutcomes.eu/
Transform - https://transformalliance.eu
RWE4Decisions - https://rwe4decisions.com/
Organisation Members: EFPIA: http://www.efpia.eu
Europabio http://www.europabio.org
EUCOPE http://www.eucope.org
AMCHAM EU: http://www.amchameu.eu
BRITCHAM EU: https://www.britcham.eu/